In pre-manifest HD patients, positron emission tomography studies have revealed widespread reductions in CB1R availability [4, 5], while various transgenic HD mouse models consistently show early striatal CB1R loss [6–11]. The gene discussed is CNR1; the disease is Huntington disease.